In this issue of Angiology, Posso et al reviewed the literature and provided evidence-based recommendations regarding the management of nonruptured abdominal aortic aneurysms (AAAs). 1 Based on their findings, they suggest open surgical repair (OSR) for low-risk patients 80 years of age, whereas they recommend endovascular aneurysm repair (EVAR) for low-risk patients >80 years of age, as well as for high-risk patients (irrespective of their age) provided the AAA anatomy is suitable. 1 Finally, they suggest OSR in patients with AAA anatomy unsuitable for EVAR. 1 This editorial considers some additional aspects regarding this topic.
Recommendations of International Guidelines
In 2018, both the American Society for Vascular Surgery (SVS) 2 and the European Society for Vascular Surgery (ESVS) 3 updated their guidelines for the management of AAAs. According to the SVS guidelines, in the United States, EVAR has become the treatment of choice for the management of AAAs. 2 Open surgical repair is indicated for patients who do not meet the anatomic requirements for EVAR (eg, short/angulated necks, tortuous access vessels with concomitant occlusive peripheral arterial disease, etc), although it was recognized that fenestrated, branched, and chimney/snorkel grafts have expanded the range of complex AAAs treated with EVAR. 2 In contrast, for high-risk and unfit patients, the SVS guidelines suggest informing these patients of the perioperative mortality risk for them to make an informed decision to proceed with AAA repair. 2 Similarly, the more recent ESVS guidelines recommend that in most patients with suitable anatomy and reasonable life expectancy, EVAR should be considered as the preferred treatment modality. 3 In contrast and similar to Posso et al, 1 in patients with long-life expectancy, OSR should be considered as the preferred treatment modality. 3 Finally, in patients with limited life expectancy, the ESVS guidelines do not recommend elective AAA repair. 3 A recent article compared thresholds for AAA repair and AAA outcomes in England and the United States. 4 .0%, respectively; P < .001). In-hospital mortality was considerably lower for patients undergoing EVAR compared to OSR both in England (0.9% vs 4.1%, respectively; P < .001) and in the United States (0.8% vs 4.0%, respectively; P < .001). 4 The rate of 3-year survival was similar between EVAR and OSR both in England (76.6% vs 78.1%; P value not mentioned) and in the United States (79.8% vs 79.1%; P value not mentioned). This finding suggests that the increased rate of AAA repair in the United States did not come at the expense of greater perioperative or postoperative risk. In contrast, AAA-related death following AAA rupture was more common in England and in the United States (OR: 3.60; 95% CI: 3.55-3.64; P < .001). The mean AAA diameter at the time of repair was larger in England compared to the United States (63.7 vs 58.3 mm, respectively; P < .001). Finally, hospitalization due to an AAA rupture occurred more frequently in England than in the United States (OR: 2.23; 95% CI: 2.19-2.27; P < .001). 4 These findings argue that the decision-making criteria may need to be reconsidered with the establishment of endovascular procedures as the preferred treatment modality for the management of AAAs. 5, 6 These data also support the SVS 2 and ESVS 3 guidelines that recommend EVAR over OSR for most patients.
The optimal management of high-risk patients is controversial. The EVAR-2 trial randomized 404 frail patients with an AAA >5.5 cm in diameter to either EVAR or no intervention.
After a mean follow-up of 4.2 years, there was no difference in the number of deaths between EVAR and no intervention (22.6 vs 22.1 deaths per 100 person-years, respectively; adjusted hazard ratio: 1.07; 95% CI: 0.86-1.34; P ¼ .52). It was therefore concluded that in patients ineligible for OSR, EVAR does not increase overall life expectancy. 7 This issue is reflected in the recent ESVS guidelines which do not recommend AAA repair for high-risk patients with limited life expectancy. 3 Three studies demonstrate that the decision to offer AAA repair should be individualized for different patients depending on their general fitness and their individual perioperative risk. In the first report, 8 112 AAA patients who were turned down for elective repair (median AAA diameter at turndown: 63 mm) were followed up for a minimum of 2 years. Within 2 years, 64 (57.1%) of 112 patients had died. Of these, 30 individuals had a recorded cause of death. Ruptured AAA was the cause of death in 11 of 30 (36.7%) patients. 8 Although it should be acknowledged that 36.7% is not a negligible percentage, based on the limited information available, the majority of AAA patients who were turned down for elective repair and subsequently died did not die of a ruptured AAA but of another cause. 8 The second article is a 20-year retrospective analysis of a single-center AAA surveillance database (n ¼ 692; AAA patients). 9 Overall, 214 deaths were recorded. Only 25 (11.7%) of these were AAA related, while 171 (80.3%) patients died while in surveillance from other causes, having never had AAA surgery. 9 Thus, once again, the majority of AAA patients who died did not die of a ruptured AAA. 9 The third report assessed the late survival of 138 nonoperated AAA patients. 10 After a median follow-up of 27 months, 71 (52%) patients had died, 36 (51%) of these following AAA rupture. 10 These 3 reports suggest that the AAA rupture risk potential should be reconsidered in high-risk patients unfit for elective repair as most high-risk patients with an AAA die from another cause rather than a ruptured AAA. Risk prediction models are available to predict both operative risk and mortality, 11 as well as postoperative life expectancy, 12 and may help guide clinical decisions. Due to the increased life expectancy and the vast improvements in endovascular techniques, the optimal management of patients with an AAA is an evolving issue. Several parameters should be taken into account (eg, morphological variables, growth of AAA, eccentric morphology, concomitant iliac artery aneurysms, infrarenal neck morphology, etc). Clinical variables are also relevant (eg, family history, clinical risk profile, etc). Most importantly, patient perception of the disease and patient preferences should be considered. Finally, institutional and individual surgical experience matters with respect to short-term outcomes, patient selection, and follow-up. Centralization of aortic service should strongly be considered to optimize outcomes.
However, certain high-risk patients may sometimes benefit more by not being offered any intervention. The perioperative mortality and morbidity risk associated with any procedure (either EVAR or OSR) should always be counterbalanced with the life expectancy and the quality of life of the patient.
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